...
首页> 外文期刊>Journal of cutaneous pathology >Histiocytoid Sweet syndrome harboring an isocitrate dehydrogenase 1 mutation: A case report and retrospective analysis of 29 cases of histiocytoid Sweet syndrome
【24h】

Histiocytoid Sweet syndrome harboring an isocitrate dehydrogenase 1 mutation: A case report and retrospective analysis of 29 cases of histiocytoid Sweet syndrome

机译:含有异偶脱氢酶1突变的组织糖醇甜综合征:组织糖醇综合征29例案例报告及回顾性分析

获取原文
获取原文并翻译 | 示例
           

摘要

Histiocytoid Sweet syndrome (HSS) is a rare histopathologic variant of Sweet syndrome that demonstrates dermal and/or subcutaneous infiltrate with a prominent component of myeloid cells resembling histiocytes. It has been known to occur in association with hematologic neoplasms, including myelodysplastic syndrome (MDS) and acute myelogenous leukemia, but whether it confers an increased risk of such neoplasms is controversial. Here, we describe a case of a HSS that led to the diagnosis of MDS with an isocitrate dehydrogenase 1 (IDH‐1) mutation and a corresponding study looking for additional cases of IDH‐1 mutations in biopsies of histiocytoid and conventional Sweet syndrome.
机译:组织纤维醇甜综合征(HSS)是甜综合征的罕见组织病理学变体,其表明皮肤和/或皮下浸润,其与类似于组织细胞的髓细胞的突出成分。 已知与血液学肿瘤相关联,包括骨髓增生术综合征(MDS)和急性髓性白血病,但它是否赋予此类肿瘤的风险增加是争议的。 在这里,我们描述了一种HSS的情况,其导致与异偶联脱氢酶1(IDH-1)突变(IDH-1)突变的MDS的诊断和相应的研究寻找组织肌细胞曲线和常规甜综合度的活组织检查中的IDH-1突变的额外情况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号